Navigation Links
InQ Biosciences Appoints John Ryder as Senior Vice President, Sales & Marketing
Date:8/3/2010

HUNTSVILLE, Ala. and MARLBOROUGH, Mass., Aug. 3 /PRNewswire/ -- InQ Biosciences Corporation, a provider of innovative technologies for cell growth and research, announced the appointment of John Ryder as Senior Vice President, Sales and Marketing. Ryder will be based in InQ's sales office in Marlborough, Massachusetts.

"Mr. Ryder's responsibilities will include developing our sales channels, creating a strategic marketing plan, and building the InQ brand around the world," said Dick Reeves, Chairman and Chief Executive Officer, InQ Biosciences.

"With his deep life sciences experience, he is the ideal executive to help us commercialize and launch the InQ Cell Research System. We are locating Mr. Ryder in the Boston area -- the center of the stem cell and neuroscience research markets that will so greatly benefit from our exciting new technology," Reeves said.

InQ is the first fully integrated system that creates a true in vivo environment for studying sensitive nerve, brain, and other human cells for disease research. It is the only cell research instrument that combines a dynamic software-controlled sample environment with powerful imaging and real-time data collection. These unique capabilities enable researchers to achieve unprecedented cell culture control, viability, and visibility that was previously unattainable.

Ryder brings over 20 years of life science sales, marketing, and business development leadership to InQ Biosciences. He joined the company from Skyscape, Marlborough, Massachusetts, a provider of trusted medical information for hand-held and mobile devices, where he was Senior Vice President of Sales. In that role, Ryder was instrumental in facilitating the acquisition of Skyscape in July 2009 by Physicians Interactive and Perseus, a $2 billion private equity firm. He also led sales and marketing for Advanced Instruments, Norwood, Massachusetts, a leading provider of microbiology research instrumentation to the pharmaceutical, industrial, and research markets. In addition, Ryder held sales management positions with Baxter Healthcare, Becton Dickinson Corporation, and Fisher Scientific. He holds a BS degree in Health Science Education from Springfield College in Massachusetts.

About InQ Biosciences

InQ Biosciences is a provider of innovative technologies for cell growth and research. The company's InQ Cell Research System will empower scientists to unlock novel and more powerful approaches to cell-based discovery. The firm was founded in 2007 with technology originating from the University of Alabama in Huntsville. Series B financing was completed in May 2010 and commercial launch of its InQ system is scheduled for the fourth quarter of 2010. For more information, visit www.inqbio.com. Follow InQ Biosciences on Twitter at @InQbio (http://twitter.com/InQbio).

Available Topic Expert(s): For information on the listed expert(s), click appropriate link.

Aaron Hammons

https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=96140


'/>"/>
SOURCE InQ Biosciences Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Neurocrine Biosciences Announces Conference Call and Webcast to Report Second Quarter 2010 Financial Results
2. Award Winning Mayo Clinic Scientist Joins Cardio3 BioSciences
3. SeqWrights Partnership with EraGen Biosciences Contributes to FDA Market Clearance Success
4. Signum Biosciences, Inc. Announces Commercial Launch of Arazine™
5. Sangamo BioSciences Announces Nature Biotechnology Study Demonstrating the Use of Zinc Finger Nucleases to Generate HIV Resistant Human Stem Cells
6. Sangamo BioSciences Receives Michael J. Fox Foundation Funding to Develop Novel Drug for the Treatment of Parkinsons Disease
7. Regado Biosciences to Present at the 2010 Wells Fargo Healthcare Conference on June 24, 2010 in Boston, Massachusetts
8. -- Neurocrine Announces a Second Corporate Collaboration Within Twenty-Four Hours -- Neurocrine Biosciences Announces a Worldwide Collaboration With Boehringer Ingelheim to Research and Develop GPR119 Agonists for Type II Diabetes
9. Sangamo BioSciences Announces First Quarter 2010 Conference Call and Webcast
10. Neurocrine Biosciences to Present at the Deutsche Bank 35th Annual Health Care Conference
11. Ampio Pharmaceuticals to Acquire DMI Biosciences, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2017)... Sept. 22, 2017 Janssen Biotech, Inc. (Janssen) ... letter from the U.S. Food and Drug Administration (FDA) ... sirukumab for the treatment of moderately to severely active ... clinical data are needed to further evaluate the safety ... active RA. ...
(Date:9/19/2017)... --  ZirMed Inc ., a recognized leader in cloud-based revenue ... been ranked #1 by its users for the seventh consecutive ... Survey. ZirMed was recognized as the top-ranked end-to-end revenue cycle ... over 200 beds and holds one of the longest #1 ... ...
(Date:9/12/2017)... PARIS and NEW YORK , Sept. 12, ... ethical performance ratings for global supply chains, has published the first annual ... the CSR performance of more than 20,400 companies evaluated by EcoVadis, based ... years 2015 and 2016. ... EcoVadis Global CSR Risk & Performance Index ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... The American Board of Family Medicine's (ABFM) ... and Chief Executive Officer, succeeding Dr. James C. Puffer upon his retirement. Dr. Newton ... until Dr. Puffer’s retirement at the end of 2018. Upon assuming the role of ...
(Date:10/13/2017)... Shelton, CT (PRWEB) , ... October 13, 2017 , ... ... and long-term care services, staged a mock evacuation of the facility as part of ... Department, Shelton Fire Department, Echo Hose EMS and Shelton City Emergency Manager, as well ...
(Date:10/13/2017)... ... ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, has released ... understood books in the Holy Scriptures, Revelation. The Book of Revelation paints a picture ... Many have tossed it off as mere rubbish, but Yisrayl Hawkins says that is ...
(Date:10/12/2017)... ... October 12, 2017 , ... First Healthcare Compliance (FHC), ... will showcase a range of technology and learning solutions at the 68th Annual ... Expo to be held October 14–18, 2017 at the Mandalay Bay Resort in ...
(Date:10/12/2017)... MD (PRWEB) , ... October 12, 2017 , ... The ... of Excellence to Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual ... – 8. , In honor of Morris F. Collen, a pioneer in the field ...
Breaking Medicine News(10 mins):